This content is no longer available for credit. Accreditation for this activity expired April 17, 2017.
Vulvodynia: A Common and Under-Recognized Pain Disorder in Women and Female Adolescents -- Integrating Current Knowledge into Clinical Practice
*Nifedipine did not exceed placebo among women with vulvodynia in a double-blind study (107). Other topicals that are not useful include corticosteroids, progesterone, and antifungals (108).